Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novartis AG (NYSE:NVS)

77.03
Delayed Data
As of Apr 28
 -0.03 / -0.04%
Today’s Change
66.93
Today|||52-Week Range
83.58
+5.75%
Year-to-Date
Pharma Stock Roundup: Lilly, Bristol-Myers, Novartis Q1 Earnings & More
Apr 28 / Zacks.com - Paid Partner Content
Key Factors to Look Out for in Celgene's (CELG) Q1 Results
Apr 25 / Zacks.com - Paid Partner Content
Amgen (AMGN) Q1 Earnings Top, Sales Miss, Shares Decline
Apr 27 / Zacks.com - Paid Partner Content
Earnings Scheduled For April 25, 2017
Apr 25 / Benzinga - Paid Partner Content
The Medicines Company (MDCO) Q1 Loss Wider Than Expected
Apr 27 / Zacks.com - Paid Partner Content
Novartis Shares Jump After Group Holds To Full Year Forecasts; Sees Entresto Growth
Apr 25 / TheStreet.com - Paid Partner Content
Tmd & Associates, Inc Buys WisdomTree MidCap Earnings Fund, WisdomTree SmallCap Earni...
Apr 26 / GuruFocus News - Paid Partner Content
Gw Henssler & Associates Ltd Buys iShares Core S&P Small-Cap, Gilead Sciences, ...
Apr 24 / GuruFocus News - Paid Partner Content
Novartis Releases 1st-Quarter Earnings
Apr 26 / GuruFocus News - Paid Partner Content
Drug Stocks Q1 Earnings Releases on Apr 25: LLY, BIIB, NVS
Apr 24 / Zacks.com - Paid Partner Content
Surveying the NASH Drug Landscape
Apr 26 / TheStreet.com - Paid Partner Content
What's in Store for GlaxoSmithKline (GSK) in Q1 Earnings?
Apr 21 / Zacks.com - Paid Partner Content
Jerome Dodson Comments on Novartis
Apr 26 / GuruFocus News - Paid Partner Content
Pharma Stock Roundup: J&J Slips on Mixed Q1, Lilly Hit by FDA CRL
Apr 21 / Zacks.com - Paid Partner Content
Surveying the NASH Liver-Disease Drug Landscape
Apr 26 / TheStreet.com - Paid Partner Content
Novartis (NVS) Q1 Earnings: Will the Stock Disappoint?
Apr 20 / Zacks.com - Paid Partner Content
What Awaits Aerie Pharmaceuticals (AERI) in Q1 Earnings?
Apr 26 / Zacks.com - Paid Partner Content
Novartis' (NVS) CTL109 BLA Gets Breakthrough Therapy Status
Apr 19 / Zacks.com - Paid Partner Content
Novartis, Amgen Divvy Global Marketing of New Migraine Drug
Apr 25 / TheStreet.com - Paid Partner Content
Allergan (AGN) Collaborates with Novartis to Treat NASH
Apr 19 / Zacks.com - Paid Partner Content
Novartis Tops Q1 Earnings: Cosentyx, Entresto Boost Sales
Apr 25 / Zacks.com - Paid Partner Content
Novartis (NVS) Up 7.7% Since Earnings Report: Can It Continue?
Apr 18 / Zacks.com - Paid Partner Content